NCT01696604 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01694329 Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, Canada Status UNKNOWN Phase N/A
NCT01693185 Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy Status COMPLETED Phase PHASE4
NCT01692496 Activity and Tolerability of Pazopanib in Advanced and/or Metastatic Liposarcoma. A Phase II Clinical Trial Status COMPLETED Phase PHASE2
NCT01691872 Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects Status WITHDRAWN Phase PHASE1
NCT01691859 MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects Status COMPLETED Phase PHASE3
NCT01691820 A Study in Adolescent Females to Explore Cytomegalovirus Infection Status COMPLETED Phase NA
NCT01691560 Exploratory Study to Evaluate an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity Status COMPLETED Phase PHASE2
NCT01691547 A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects Status COMPLETED Phase PHASE1
NCT01691521 Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma Status COMPLETED Phase PHASE3
NCT01691508 Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma Status COMPLETED Phase PHASE3
NCT01691482 A Study to Look at Day to Day Changes in Lung Function in COPD Subjects Taking Albuterol/Salbutamol and Ipratropium Status COMPLETED Phase PHASE4
NCT01689532 A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine Status COMPLETED Phase PHASE3
NCT01687309 A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender Status COMPLETED Phase PHASE1
NCT01687296 Nebulized Fluticasone Propionate VS Oral Prednisone in Chinese Pediatric and Adolescent Subjects With an Acute Exacerbation of Asthma Status COMPLETED Phase PHASE3
NCT01687283 Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma Status COMPLETED Phase PHASE3
NCT01686646 Effects of Two Doses of a Common Cold Treatment on Alertness Status COMPLETED Phase PHASE3
NCT01686633 An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (mcg) , FF/VI 100/25 mcg, and FF 100 mcg in Adults and Adolescents With Persistent Asthma. Status COMPLETED Phase PHASE3